GiViTI – Italian Group for the Evaluation of Interventions in Intensive Care Medicine, founded in 1991,
It’s research projects are aimed at the continuous evaluation in intensive care units (ICUs) in order to improve the quality of health care and clinical research. The GiViTI network has over 330 participants in Italy.
For more information please see the website.
GISSI – Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico
It is a product of the collaboration between the Mario Negri Institute and the Associazione Nazionale dei Medici Cardiologi Ospedalieri (ANMCO). Today it is considered one of the best-qualified research teams in the cardiovascular field. GISSI has produced a series of large-scale clinical trials (GISSI 1, GISSI 2, GISSI 3, GISSI Prevenzione), involving over 60,000 patients with myocardial infarction.
In the twenty years since GISSI was set up, its studies have been widely recognized by the international cardiology community and are considered a methodological landmark.
GISSI’s work has now spread from myocardial infarction to other cardiovascular pathologies with a wide impact, like heart failure and atrial fibrillation, on which large-scale clinical studies are now in progress.
MANGO – Mario Negri Gynecologic Oncology Group
Since the beginning of the 90’s, the Institute has worked actively for the realization of clinical studies in Italy and abroad in the onco-gynaecological field. In May 2006 Mango was formally born, to continue this mission and make it more visible.
The collaboration and active participation of the Mango group in the main international networks of oncological gynecology – Gynecologic Cancer Intergroup (GCIG) and European Network of Gynaecological Oncolgical Trial groups (ENGOT) - has led to the development of important clinical research and more specific subgroups.
Intercheck web: web application aimed at health professionals to support the proper prescription of drugs in the elderly.
